Precision Oncology Today
As healthcare increasingly becomes informed by the analysis—via machine learning and artificial intelligence—of patient-specific, or disease-specific data, a new tool is steadily making its way onto the scene: patient digital twins. Digital twin technology promises to impact precision medicine from clinical trials to clinical care—in silico.
A flurry of microbiome research over the past two decades has led to many insights about the link between the microbes and health, but now the race to the clinic is on. Our understanding of the microbiome has been greatly advanced thanks to the improvements in next-generation sequencing techniques.
Trending on Inside Precision Medicine
Research suggests that a ketogenic diet could counteract the reduced platelet counts often seen in cancer patients receiving chemotherapy.
Tevogen announced it will begin work to study potential therapeutic use of its allogeneic genetically unmodified precision T cell technology in multiple sclerosis (MS) by developing Epstein-Barr virus (EBV) specific CD8+ cytotoxic T lymphocytes.
Gene editing start up iECURE announced a $65 million financing for its lead liver disease program, which is in partnership with Jim Wilson's group at University of Pennsylvania.